SavedAdd your journal

Journals / Annals of Medical Research / 2020 / Cilt: 27 - Sayı: 3

The relationship between betatrophin levels and HbA1c: A case control study

Ferit GURSU
Erhan ONALAN
İhsan SOLMAZ
Buray YAKAR
Mesut KILIÇOĞLU
Pages
852–856
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Betatrophin levels of patientswith uncontrolled diabetes were significantly higher than control group and controlled diabetic group.(p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In our study, we first aimed to investigate the effect of betatrophin in uncontroled diabetes patients with HbA1c above 14.Another focus of our study is the effect of betatrophin levels on the biochemical parameters of the patients.Material and Methods: This is an observational study with a prospective case-control design.
📊
Key Findings & Data:The study was carried out betweenJuly 2018 and November 2018 at the internal medicine clinic of the tertiary university hospital.
💡
Conclusion & Impact:Betatrophin levels of patientswith uncontrolled diabetes were significantly higher than control group and controlled diabetic group.(p
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: In our study, we first aimed to investigate the effect of betatrophin in uncontroled diabetes patients with HbA1c above 14.Another focus of our study is the effect of betatrophin levels on the biochemical parameters of the patients.Material and Methods: This is an observational study with a prospective case-control design. The study was carried out betweenJuly 2018 and November 2018 at the internal medicine clinic of the tertiary university hospital. Our study was conducted withparticipants divided into 3 groups. Group 3 (uncontrolled T2DM) consisted of 40 participants who met the study criteria and HbA1cabove 14% . Group 2 (controlled T2DM) consisted of 40 participants who met the study criteria and HbA1c below %10 and the group1 (control group) consisted of 40 people who did not have a history of diabetes mellitus.Results: There was no statistical difference in age and sex between the 3 groups included in the study. Betatrophin levels of patientswith uncontrolled diabetes were significantly higher than control group and controlled diabetic group.(p

🔖

Cite This Article

GURSU, F., ONALAN, E., SOLMAZ, İ., YAKAR, B., KILIÇOĞLU, M. (2022). The relationship between betatrophin levels and HbA1c: A case control study. Annals of Medical Research, Cilt: 27 - Sayı: 3, 852–856. https://ajindex.com/articles/446145

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Glisemik Bozukluklarda Tanı, Sınıflama ve Tarama. TEMD Diyabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu
  2. Baskı, Türk Endokrinoloji ve Metabolizma Derneği, 2019:15-27
  3. Crandall J and Shamoon H. Diabetes Mellitus. In: Lee G, Andrew IS, eds. GoldmanCecil Medicine
  4. Edition,Philadelphia, Elsevier Saunders 2016:1527- 48
  5. Yi P, Park JS, Melton DA. Betatrophin: A hormone that controls pancreatic beta cell proliferation. Cell 2013;153:747-58
  6. Chen J, Chen S, Huang P, et al. In vivo targeted delivery of ANGPTL8 gene for beta cell regeneration in rats. Diabetologia 2015;58:1036-44
  7. Jiao Y, Le Lay J, Yu M, et al. Elevated mouse hepatic betatrophin expression does not increase human beta-cell replication in the transplant setting. Diabetes 2014;63:1283-8
  8. Zhang Y, Li S, Donelan W, et al. Angiopoietin-like protein 8 (betatrophin) is a stress-response protein that down-regulates expression of adipocyte triglyceride lipase. Biochim Biophys Acta 2016;1861:130-7
  9. Zhang R. Lipasin, a novel nutritionally-regulated liverenriched factor that regulates serum triglyceride levels, Biochem Biophys Res Commun 2012;424;786- 92
  10. Gokulakrishnan K, Manokaran K, Pandey GK, Amutha A, Ranjani H, Anjana RM, et al. Relationship of betatrophin with youth onset type 2 diabetes among Asian Indians. Diabetes Res Clin Pract 2015;109:71-6
  11. Gomez-Ambrosi J, Pascual E, Catalan V,, et al. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metabol 2014;99: 2004-9
  12. Hu H, Sun W, Yu S, et al. Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diabetes Care 2014;37:2718-22
  13. Chen X, Lu P, He W, et al. Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance. J Clin Endocrinol Metab 2015;100:96-100
  14. Espes D, Martinell M. Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int J Endocrinol 2014;2014:323407
  15. Sheyu Li, Dan Liu, Ling Li, et al. “Circulating Betatrophin in Patients with Type 2 Diabetes: A Meta-Analysis,” Journal of Diabetes Research. 2016;2016:9 14. Fenzl A, Itariu BK, Kosi L, F et al. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia. 2014;57:1204-8
  16. Ebert T, Kralisch S, Hoffmann A, et al. Circulating angiopoietin-like protein 8 i